Office of National Drug Control Policy

• Pages: 94-95

Office of National Drug Control Policy

Executive Office of the President, Washington, DC 20503

Phone, 202-395-6700. Fax, 202-395-6708. Internet, www.ondcp.gov.

DIRECTOR R. Gil Kerlikowske

Deputy Director A. Thomas McLellan

Deputy Director for Demand Reduction Martha Gagne, Acting

Deputy Director for State, Local, and Tribal Michael K. Gottlieb, Affairs Acting

Deputy Director for Supply Reduction Patrick M. Ward, Acting

Associate Director, Performance and Budget Jon E. Rice

Associate Director, Legislative Affairs Deborah J. Walker, Acting

Associate Director, Management and Michele C. Marx

Administration

Associate Director, Public Affairs Rafael Lemaitre, Acting

General Counsel Daniel R. Petersen, Acting

Chief Scientist, Counter-Drug Technology David W. Murray

Assessment Center

Associate Director, National Youth Anti-Drug Robert W. Denniston

Media Campaign

------------------------------------------------------------------------

The Office of National Drug Control Policy assists the President in establishing policies, priorities, and objectives in the National Drug Control Strategy. It also provides budget, program, and policy recommendations on the efforts of National Drug Control Program agencies.

The Office of National Drug Control Policy was established by the National Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.), effective January 29, 1989, reauthorized through the Office of National Drug Control Policy Reauthorization Act of 1988 (21 U.S.C. 1701 et seq.), and again reauthorized through the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 1701 et seq.).

The Director of National Drug Control Policy is appointed by the President with the advice and consent of the Senate. The Director is assisted by a Deputy Director, a Deputy Director for Demand Reduction, a Deputy Director for Supply Reduction, and a Deputy Director for State, Local, and Tribal Affairs.

The Director is responsible for establishing policies, objectives, priorities, and performance measurements for the national drug control program, as well as for annually promulgating drug control strategies and supporting reports and a program budget, which the President submits to Congress...